KRSNAA DIAGNOSTICS LTD (KRSNAA) financials

KRSNAA DIAGNOSTICS LTD (KRSNAA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

Market Cap: ₹1,730Cr.
Current Price: ₹533
Stock P/E: 17.5
ROE: 10.9%
ROCE: 12.7%
Book Value: ₹306
Dividend Yield: 0.38%
52W High / Low: ₹847/502

In Jun 2026, KRSNAA DIAGNOSTICS LTD (KRSNAA) reported sales ₹211 Cr and net profit ₹16 Cr.

Annual TTM: sales ₹726 Cr, net profit ₹99 Cr.

Shareholding: Promoters 27.11% (Sep 2026), FIIs 3.84% (Sep 2026), DIIs 14.50% (Sep 2026), Public 54.55% (Sep 2026), No. of Shareholders 50,671% (Sep 2026).

KRSNAA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	179	165	175	176	183	159	173	211
Expenses	126	117	121	126	125	112	116	154
Operating Profit	52	48	53	50	58	48	57	57
OPM %	29%	29%	31%	29%	32%	30%	33%	27%
Other Income	5	9	4	4	4	4	31	7
Interest	6	6	7	6	8	8	12	15
Depreciation	22	23	22	22	23	23	22	28
Profit before tax	28	28	29	26	31	21	54	22
Tax %	23%	24%	28%	26%	24%	22%	20%	26%
Net Profit	22	22	21	20	23	16	43	16
EPS in Rs	6.80	6.69	6.53	6.03	7.16	5.08	13.37	4.88
Raw PDF	—	—	—	—	—	—	—	—

KRSNAA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	258	396	455	464	590	682	691	726
Expenses	373	302	320	340	444	485	478	507
Operating Profit	-114	94	135	124	146	197	213	219
OPM %	-44%	24%	30%	27%	25%	29%	31%	30%
Other Income	13	265	15	19	17	26	43	47
Interest	25	26	18	8	16	25	34	42
Depreciation	32	37	41	54	75	88	90	96
Profit before tax	-158	295	90	82	72	110	132	128
Tax %	-29%	37%	21%	23%	19%	24%	22%	—
Net Profit	-112	185	71	64	59	83	103	99
EPS in Rs	-108.69	142.25	22.52	20.23	18.14	25.65	31.65	30.49
Dividend Payout %	0%	0%	11%	14%	14%	11%	6%	—

KRSNAA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	5	6	16	16	16	16	16
Reserves	43	-217	-17	671	727	799	877	976
Borrowings	330	246	474	41	32	160	202	531
Other Liabilities	115	596	146	149	134	197	188	295
Total Liabilities	493	630	609	877	909	1,172	1,283	1,818
Fixed Assets	223	275	309	386	471	647	668	651
CWIP	42	9	4	28	25	10	3	208
Investments	0	0	0	0	0	0	32	58
Other Assets	228	345	297	463	413	514	581	902
Total Assets	493	630	609	877	909	1,172	1,283	1,818

KRSNAA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	61	38	119	129	75	24	89	134
Cash from Investing Activity	-201	-77	-67	-241	-109	-129	-102	-391
Cash from Financing Activity	145	6	20	176	-33	84	14	278
Net Cash Flow	4	-33	71	64	-66	-20	1	22
Free Cash Flow	-42	-39	50	-2	-59	-169	-21	-80
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	114%	-42%	134%	100%	71%	30%	55%	75%

KRSNAA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	27.24%	27.24%	27.11%	27.11%	27.11%	27.11%	27.11%	27.11%
FIIs	4.04%	3.55%	3.40%	3.66%	4.17%	3.91%	4.28%	3.84%
DIIs	14.46%	14.26%	14.24%	14.96%	13.85%	13.89%	14.51%	14.50%
Public	54.27%	54.94%	55.25%	54.27%	54.86%	55.09%	54.08%	54.55%
No. of Shareholders	52,799	53,559	54,262	52,117	52,380	53,022	53,625	50,671

KRSNAA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	140	87	69	48	59	110	152	163
Inventory Days	89	—	—	—	—	—	—	—
Days Payable	878	—	—	—	—	—	—	—
Cash Conversion Cycle	-650	87	69	48	59	110	152	163
Working Capital Days	-234	-133	-82	-21	16	-18	28	66
ROCE %	—	-65%	129%	18%	12%	10%	13%	13%

KRSNAAUpdated 18 Oct 2026, 18:36

Krsnaa Diagnostics Ltd

KRSNAAUpdated 18 Oct 2026, 18:36

Market Cap

₹1,730Cr.

Current Price

₹533

High / Low

₹847/502

Stock P/E

17.5

ROE10.9%

ROCE12.7%

Book Value₹306

Face Value₹5.00

Dividend Yield0.38%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	132	2	100	4	16	19	18	15	4.86
Sep 2023	147	3	116	4	18	14	20	11	3.6
Dec 2023	152	4	113	4	21	17	20	14	4.21
Mar 2024	159	7	116	4	18	22	17	18	5.7
Jun 2024	163	5	120	7	21	24	23	18	5.63
Sep 2024	179	6	126	5	22	28	23	22	6.8
Dec 2024	165	6	117	9	23	28	24	22	6.69
Mar 2025	175	7	121	4	22	29	28	21	6.53
Jun 2025	176	6	126	4	22	26	26	20	6.03
Sep 2025	183	8	125	4	23	31	24	23	7.16
Dec 2025	159	8	112	4	23	21	22	16	5.08
Mar 2026	173	12	116	31	22	54	20	43	13.37
Jun 2026	211	15	154	7	28	22	26	16	4.88

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2016	36	6	35	3	5	-7	6	-8	-7.54
Mar 2017	57	6	42	4	10	2	8	2	2.01
Mar 2018	108	8	169	3	18	-84	-29	-60	-58.41
Mar 2019	147	16	87	2	26	21	40	12	12.11
Mar 2020	258	25	373	13	32	-158	-29	-112	-108.69
Mar 2021	396	26	302	265	37	295	37	185	142.25
Mar 2022	455	18	320	15	41	90	21	71	22.52
Mar 2023	464	8	340	19	54	82	23	64	20.23
Mar 2024	590	16	444	17	75	72	19	59	18.14
Mar 2025	682	25	485	26	88	110	24	83	25.65
Mar 2026	691	34	478	43	90	132	22	103	31.65
TTM	726	42	507	47	96	128	—	99	30.49

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	27.11%
FIIs	3.84%
DIIs	14.5%
Public	54.55%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	27.03%	3.44%	16.59%	52.94%
Mar 2024	27.03%	3.34%	15.37%	54.27%
Jun 2024	27.17%	3.33%	15.26%	54.23%
Sep 2024	27.17%	3.63%	15.86%	53.34%
Dec 2024	27.24%	4.04%	14.46%	54.27%
Mar 2025	27.24%	3.55%	14.26%	54.94%
Jun 2025	27.11%	3.4%	14.24%	55.25%
Sep 2025	27.11%	3.66%	14.96%	54.27%
Dec 2025	27.11%	4.17%	13.85%	54.86%
Mar 2026	27.11%	3.91%	13.89%	55.09%
Jun 2026	27.11%	4.28%	14.51%	54.08%
Sep 2026	27.11%	3.84%	14.5%	54.55%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2016	5	4	131	24	163	59	20	0	85	163
Mar 2017	5	6	102	63	176	116	6	0	53	176
Mar 2018	—	—	—	—	—	—	—	—	—	—
Mar 2019	5	43	330	115	493	223	42	0	228	493
Mar 2020	5	-217	246	596	630	275	9	0	345	630
Mar 2021	6	-17	474	146	609	309	4	0	297	609
Mar 2022	16	671	41	149	877	386	28	0	463	877
Mar 2023	16	727	32	134	909	471	25	0	413	909
Mar 2024	16	799	160	197	1172	647	10	0	514	1172
Mar 2025	16	877	202	188	1283	668	3	32	581	1283
Mar 2026	16	976	531	295	1818	651	208	58	902	1818

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2016	—	—	—	—
Mar 2017	59	-53	-37	-31
Mar 2018	—	—	—	—
Mar 2019	61	-201	145	4
Mar 2020	38	-77	6	-33
Mar 2021	119	-67	20	71
Mar 2022	129	-241	176	64
Mar 2023	75	-109	-33	-66
Mar 2024	24	-129	84	-20
Mar 2025	89	-102	14	1
Mar 2026	134	-391	278	22

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	87	91	—	140	87	69	48	59	110	152	163
Inventory Days	21	24	—	89	—	—	—	—	—	—	—
Days Payable	76	99	—	878	—	—	—	—	—	—	—
Cash Conversion Cycle	32	15	—	-650	87	69	48	59	110	152	163
Working Capital Days	-428	-119	—	-234	-133	-82	-21	16	-18	28	66
ROCE %	—	7%	—	—	-65%	129%	18%	12%	10%	13%	13%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of KRSNAA DIAGNOSTICS LTD (KRSNAA)?

The reported market capitalisation for KRSNAA DIAGNOSTICS LTD (KRSNAA) is ₹1,730Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of KRSNAA?

The current price shown for KRSNAA DIAGNOSTICS LTD (KRSNAA) on Fincrux is ₹533 with a 52-week high/low of ₹847/502.

What is the P/E ratio of KRSNAA DIAGNOSTICS LTD (KRSNAA)?

The stock P/E for KRSNAA DIAGNOSTICS LTD (KRSNAA) is 17.5 on Fincrux, with ROE at 10.9% and ROCE at 12.7%.

What were KRSNAA latest quarterly results?

For Jun 2026, KRSNAA DIAGNOSTICS LTD (KRSNAA) reported sales ₹211 Cr and net profit ₹16 Cr (figures in ₹ crore unless noted).

What are KRSNAA annual sales and net profit?

For TTM, KRSNAA DIAGNOSTICS LTD (KRSNAA) shows sales of ₹726 Cr and net profit of ₹99 Cr on the Fincrux profit & loss statement.

Who owns KRSNAA DIAGNOSTICS LTD (KRSNAA)?

Latest shareholding for KRSNAA DIAGNOSTICS LTD (KRSNAA) on Fincrux: Promoters 27.11% (Sep 2026), FIIs 3.84% (Sep 2026), DIIs 14.50% (Sep 2026), Public 54.55% (Sep 2026), No. of Shareholders 50,671% (Sep 2026).

Where can I find KRSNAA DIAGNOSTICS LTD (KRSNAA) financials?

KRSNAA DIAGNOSTICS LTD (KRSNAA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show KRSNAA balance sheet and cash flow?

Yes. The KRSNAA DIAGNOSTICS LTD (KRSNAA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 18:36